Breaking News

SAFC Expands Continuous Flow Capabilities

May 20, 2014

Enhances lean manufacturing platform

SAFC Commercial, the custom manufacturing business of Sigma-Aldrich, has installed a new commercial-scale continuous flow reactor at its Sheboygan, WI, facility, with capacity to produce as much as 150 kg of product per day. The company also has a smaller pilot-scale continuous flow reactor that’s being fabricated at its nearby Milwaukee facility for process optimization studies and manufacturing capability of as much as 30 kg of product per day.
Continuous flow manufacturing aims to provide customers access to as little or as much product as needed. According to the company, the nature of this technique offers safer, seamless scale-up of a wider array of reactions compared to the batch platform, and may help customers achieve process control, while helping to eliminate batch failures and minimize risks with handling hazardous chemicals.
"SAFC has invested in making these unique capabilities available to give customers access to products synthesized through reactions that were previously impractical or impossible to do with a conventional batch platform," said Andreas Weiler, director of Global Strategic Marketing for SAFC. "The reactors will allow SAFC to develop or scale up flow reactions for customers, eliminating the need for customers to install in-house flow capacity, saving them a great deal of money, space and time. This is also a much greener technology and substantially reduces the amount of chemicals and solvents employed in reactions."

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision